Research ArticleOsteoarthritis

Paroxetine-mediated GRK2 inhibition is a disease-modifying treatment for osteoarthritis

See allHide authors and affiliations

Science Translational Medicine  10 Feb 2021:
Vol. 13, Issue 580, eaau8491
DOI: 10.1126/scitranslmed.aau8491

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article